Back to Search
DR. SUCHA O ASBELL MD
MD
Radiation Oncology Physician
NPI: 1770699605IndividualAccepts Medicare
Specialties, Licenses & Credentials
Therapeutic Radiology Physician
Radiology — Therapeutic Radiology
Code: 2085R0203X
MD009376E(PA)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
25MA08110400(NJ)MD009376E(PA)
Education
WOMAN'S MEDICAL COLLEGE
Class of 1966
Research & Publications (15)
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
PMID 18990504·Int J Radiat Oncol Biol Phys·2009
3-trial
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
PMID 17634487·J Clin Oncol·2007
3-trial
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.
PMID 17531401·Int J Radiat Oncol Biol Phys·2007
3-trial
Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
PMID 17398031·Int J Radiat Oncol Biol Phys·2007
8-other
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
PMID 17011443·Int J Radiat Oncol Biol Phys·2006
2-rct
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
PMID 15817329·Int J Radiat Oncol Biol Phys·2005
3-trial
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
PMID 12743142·J Clin Oncol·2003
3-trial
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
PMID 12478146·J Urol·2003
8-other
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.
PMID 12871784·Lung Cancer·2003
8-other
Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
PMID 11745507·Int J Cancer·2001
8-other
Four prognostic groups predict long-term survival from prostate cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.
PMID 10837943·Int J Radiat Oncol Biol Phys·2000
3-trial
Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
PMID 11121651·Int J Radiat Oncol Biol Phys·2000
8-other
Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients.
PMID 11052458·J Natl Med Assoc·2000
8-other
Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials.
PMID 10894874·J Clin Oncol·2000
8-other
Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials.
PMID 10837944·Int J Radiat Oncol Biol Phys·2000
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2 COOPER PLZ
CAMDEN, NJ 08103 - Phone
- (855) 632-2667
Quick Facts
- NPI
- 1770699605
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 60
- Publications
- 15
Are you this provider?
Claim Your Profile